Modulation of catecholamine and other neutomedia-tors levels in ascs
##plugins.themes.bootstrap3.article.sidebar##
Опубликован:
Jul 5, 2020
License:
Это произведение доступно по лицензии Creative Commons «Attribution-ShareAlike» («Атрибуция — На тех же условиях») 4.0 Всемирная
Это произведение доступно по лицензии Creative Commons «Attribution-ShareAlike» («Атрибуция — На тех же условиях») 4.0 Всемирная
Раздел
Статьи
##plugins.themes.bootstrap3.article.main##
Аннотация
Currently there are a lot of reports in the literature about change of some protein levels including so called “neurospecific” regulatory peptides, a number of mediators, hormones, their metabolites and precursors in blood and other biological fluids under the effect of alcohol, narcotics, neuropsychic diseases, in hypnosis and its pharmacologic modeling’s [1, 4]. Activity of a number of enzymes, participating in the catecholamine metabolism, protein glycolyzation and other processes also under-go significant changes.
##plugins.themes.bootstrap3.article.details##
How to Cite
Мусаханова, Г. (2020). Modulation of catecholamine and other neutomedia-tors levels in ascs. Илмий тадқиқотал архиви, 1(22). Retrieved from https://ejournal.tsue.uz/index.php/archive/article/view/2600
References
Anokhina A.P., Ivanets N,N., Drobisheva V.Ya. Osnovnie dostizhenia v oblasti narkologii, toksikomanii, alkogolisma. Vestnik Ros.AMN; 1998:N ,P.29-37 (Main achievements in the field of narcology, toxicomania and alcoholism.) 2. Anokhina I.P., Veretinskaya A.G., Vekshina N.L et al. Nasledstvennii alkogolism: nekotorie neirohimicheskie i geneticheskie mehanismi. Vesntnik Ros.AMN;1999:N 6,P.43-47.(Hereditary alcoholism: some neurochemical and genetic mechanisms). 3. Badaway A., Rommelspacher H., Morgan C et al. Tryptophan metabolism in alcohol-ism. Tryptopham but not excitary amino acid availability to the brain is increased before the appear-ance of the alcohol-withdrawal syndrome in men Alcohol and metabolism,1998:Vol.33,P.616-625 4. Beresin A.V., Belik Ya.V. Spetsificheskie belki nervnoi tkani. Kiev,199-, 263 p. (Specific proteins of the nervous tissue). 5. Corea-Sales C., Rabin B.C., Maze M. A Hypnotic response to dexmedetomidine, an aplha2 agonist, is mediated in the locus coeruleus in reats. Anesthesiology;1992:Vol.76,N6,P.948-952 6. Durand G., Seta N. Protein glycosylation and disease: blood and urinary oligosaccha-
26
rides as markers for diagnosis and therapeutic monitoring. Clinical chemictry; 2000:Vol.46,P.795-805. 7. Morkovkin V.M., Kartelishev A.V. Patohimiya schizophrenii (patogeneticheskie, di-agnosticheskie i prognosticheskie aspekti). M.:Medicina, 1988, 256 p.(Pathochemistry of schizo-phrenia : pathogenic, diagnostic and prognostic aspects). 8. Kopin I.G. Biohimicheskoe opredelenie perifericheskoi adrenergicheskoi aktivnosti. In: “Osvobojdenie kateholaminov iz adrenergicheskih neironov Ed. By D.M.Paton. M.:Medicina. P.329-345. (Biochemical determination of the peripheral adrenergic activity. In: Releasing of cate-cholamines from adrenergic neurons). 9. Fromm E. Quo vadis Hypnosis? Prediction of future trends in hypnosis research. In; Hypnosis: Developments in research and new prespectives.N.Y.;1979. 10. Heinz A., Ragan P., Jones D.W. et al. Reduced central serotonin trasporters in Alco-holism. Asm.J.Psychiatry;1998;Vol.155,P.`544-`549. 11. Rabin B.C., Reid K., Guo T.Z., Gusrafsson E., Zhang C., Maze M. Sympatholytic and minimum anesthetic concentration-sparing response are preserved in rats rendered tolerant to the hypnotic and analgetic action of dexmedetomidine, a selective alpha 2-adrenergic agonist. Anesthe-siology;1996:Vol.85,N 3,P.565-573. 12. Sakellion D.N. On the possibility biochemical monitoring of psychotherapy efficien-cy during the changed state of consciousness // Medical Journal of Uzbekistan. 2000; 4; 73-75. 13. Sakellion D.N and Aripov A.N. Biochemical aspects of adolescents drug addiction diagnosis, prevention, and psychotherapy // Journal of Pediatrics (Tashkent). 2003; 1; 123-128. 14. Sakellion D.N and Alimov U.Kh. Possibilities of implementing sensory deprivation in treatment of drug addiction form the point of view of functional systems // Narcology (Moscow). 2003: 1; 49-51 15. Sakellion D.N. and Aripov A.N. Biochemical aspects of prevention, diagnosis, and psychotherapy of drug addiction in teenagers // Narcology (Moscow). 2003: 3; 17-20. 16. Sakellion D.N., Alimov U.Kx. Hypnotic analgesia as method’s non-pharmacological analgesia // Headache. Volume 20. Number 3. July – September, Athens. 2012. pp. 123 – 129. 17. Sakellion D.N. and Alimov U.Kh. Changes of metabolism and ionic homeostasis in-dicators of body’s biological liquids in brain activity disorders // Narcology (Moscow). 2011: 7 (115); 84-89. 18. Stoltenberg S.F., Burmeister M. Recent progress in psychiatric genetics - some hope but no hype. Human mol.Genetics;2000:Vol.9,N6,P.927-935.Sultanov Sh. Khodjaeva N. The state of humoral Mechanisms of the Immune system in heroin addicts. European science review, «East West» GmbH. Vienna. 5-6 (4) 2017, - Р. 45-46 19. Studerus Erich , Gamma Alex, Vollenweider Franz X. The standardized psychometric assessment of altered states of consciousness (ASCs) in humans. Pharmacopsychiatry; 1998: Vol.31, Supp l.2, P.80-84. 20. Sullivan J., Srtanfild C.,Dacks C. MAO - activity in schizophrenia. Amer.J.psychiatr.;1977:Vol.134,P.1998-2003. 21. Sultanov Sh. Khodjaeva N. Optimization of therapy clinic-immunological disorders with heroin addiction. «European psychiatry» the Journal of the European psychiatric association. The 24-th European congress of psychiatry. Madrid, Spain. 2016. 4-5 (3)- Р. 45-46 22. Sultanov Sh. Khodjaeva N. The state of humoral Mechanisms of the Immune system in heroin addicts. European science review, «East West» GmbH. Vienna. 5-6 (4) 2017, - Р. 45-46 23. Topilgo S.M. Konjugirovannie formi angiotensina II i beta-endorphina v sistemnoi organizatsii tselenapravlennogo povedenia. Vestnik Roc.AMN; 1999:N6,P.52-56. (Conjugated forms of angiotensine II and beta-endorphine in the systemic organization of the directed behavior). 24. Zurich V., Switzerland G. Parathyroid Hormone Responses to Catecholamines and to Changes of Extracellular Calcium in Cows.// The journal of Clinical Investigrtion. 1978 ; 61(5): 1113–1122.
26
rides as markers for diagnosis and therapeutic monitoring. Clinical chemictry; 2000:Vol.46,P.795-805. 7. Morkovkin V.M., Kartelishev A.V. Patohimiya schizophrenii (patogeneticheskie, di-agnosticheskie i prognosticheskie aspekti). M.:Medicina, 1988, 256 p.(Pathochemistry of schizo-phrenia : pathogenic, diagnostic and prognostic aspects). 8. Kopin I.G. Biohimicheskoe opredelenie perifericheskoi adrenergicheskoi aktivnosti. In: “Osvobojdenie kateholaminov iz adrenergicheskih neironov Ed. By D.M.Paton. M.:Medicina. P.329-345. (Biochemical determination of the peripheral adrenergic activity. In: Releasing of cate-cholamines from adrenergic neurons). 9. Fromm E. Quo vadis Hypnosis? Prediction of future trends in hypnosis research. In; Hypnosis: Developments in research and new prespectives.N.Y.;1979. 10. Heinz A., Ragan P., Jones D.W. et al. Reduced central serotonin trasporters in Alco-holism. Asm.J.Psychiatry;1998;Vol.155,P.`544-`549. 11. Rabin B.C., Reid K., Guo T.Z., Gusrafsson E., Zhang C., Maze M. Sympatholytic and minimum anesthetic concentration-sparing response are preserved in rats rendered tolerant to the hypnotic and analgetic action of dexmedetomidine, a selective alpha 2-adrenergic agonist. Anesthe-siology;1996:Vol.85,N 3,P.565-573. 12. Sakellion D.N. On the possibility biochemical monitoring of psychotherapy efficien-cy during the changed state of consciousness // Medical Journal of Uzbekistan. 2000; 4; 73-75. 13. Sakellion D.N and Aripov A.N. Biochemical aspects of adolescents drug addiction diagnosis, prevention, and psychotherapy // Journal of Pediatrics (Tashkent). 2003; 1; 123-128. 14. Sakellion D.N and Alimov U.Kh. Possibilities of implementing sensory deprivation in treatment of drug addiction form the point of view of functional systems // Narcology (Moscow). 2003: 1; 49-51 15. Sakellion D.N. and Aripov A.N. Biochemical aspects of prevention, diagnosis, and psychotherapy of drug addiction in teenagers // Narcology (Moscow). 2003: 3; 17-20. 16. Sakellion D.N., Alimov U.Kx. Hypnotic analgesia as method’s non-pharmacological analgesia // Headache. Volume 20. Number 3. July – September, Athens. 2012. pp. 123 – 129. 17. Sakellion D.N. and Alimov U.Kh. Changes of metabolism and ionic homeostasis in-dicators of body’s biological liquids in brain activity disorders // Narcology (Moscow). 2011: 7 (115); 84-89. 18. Stoltenberg S.F., Burmeister M. Recent progress in psychiatric genetics - some hope but no hype. Human mol.Genetics;2000:Vol.9,N6,P.927-935.Sultanov Sh. Khodjaeva N. The state of humoral Mechanisms of the Immune system in heroin addicts. European science review, «East West» GmbH. Vienna. 5-6 (4) 2017, - Р. 45-46 19. Studerus Erich , Gamma Alex, Vollenweider Franz X. The standardized psychometric assessment of altered states of consciousness (ASCs) in humans. Pharmacopsychiatry; 1998: Vol.31, Supp l.2, P.80-84. 20. Sullivan J., Srtanfild C.,Dacks C. MAO - activity in schizophrenia. Amer.J.psychiatr.;1977:Vol.134,P.1998-2003. 21. Sultanov Sh. Khodjaeva N. Optimization of therapy clinic-immunological disorders with heroin addiction. «European psychiatry» the Journal of the European psychiatric association. The 24-th European congress of psychiatry. Madrid, Spain. 2016. 4-5 (3)- Р. 45-46 22. Sultanov Sh. Khodjaeva N. The state of humoral Mechanisms of the Immune system in heroin addicts. European science review, «East West» GmbH. Vienna. 5-6 (4) 2017, - Р. 45-46 23. Topilgo S.M. Konjugirovannie formi angiotensina II i beta-endorphina v sistemnoi organizatsii tselenapravlennogo povedenia. Vestnik Roc.AMN; 1999:N6,P.52-56. (Conjugated forms of angiotensine II and beta-endorphine in the systemic organization of the directed behavior). 24. Zurich V., Switzerland G. Parathyroid Hormone Responses to Catecholamines and to Changes of Extracellular Calcium in Cows.// The journal of Clinical Investigrtion. 1978 ; 61(5): 1113–1122.